NCT04545528

Brief Summary

Kidney stone disease has become a common phenomenon in the US and Europe with a growing incidence of about 10%. Life style and dietary changes have a cardinal part in kidney stone prevention. Therefore it was only natural to determine the impact of the addition of a nutritionist to a stone clinic run by a urologist and a nephrologist.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 25, 2020

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 11, 2020

Completed
1.1 years until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

October 14, 2022

Status Verified

October 1, 2022

Enrollment Period

11 months

First QC Date

August 25, 2020

Last Update Submit

October 13, 2022

Conditions

Keywords

kidney stonekidney Caliculi

Outcome Measures

Primary Outcomes (1)

  • 24h Urine collection results

    to follow changes in the 24 hour urine collection results that are routinely taken as part as follow up: volume in millilitres; calcium, oxalate, magnesium, phosphorus sodium and potassium in mg/day;

    Through study completion, an average of 1 year

Secondary Outcomes (7)

  • Weight

    Through study completion, an average of 1 year

  • Height

    Through study completion, an average of 1 year

  • BMI

    Through study completion, an average of 1 year

  • Creatinin in mg/dl

    Through study completion, an average of 1 year

  • Calcium in mg/dl

    Through study completion, an average of 1 year

  • +2 more secondary outcomes

Study Arms (2)

Test group

100 Patients that were referred to our stone clinic for follow up with risk factors for stone recurrence like metabolic syndrome and diabetes, uric acid stones etc. In addition to seeing our urologist and nephrologist these patients will also be referred to a nutritionist in order to balance risk factors and will be followed for one year with our usual blood tests and imaging

Behavioral: Dietary recommendations

Control group

100 Patients that were referred to our stone clinic for follow up without risk factors for stone recurrence will see our urologist and nephrologist and will be followed for one year with our usual blood tests and imaging

Interventions

The test group will be seen by a nutritionist and will receive specific dietary recommendations according to their specific comorbidities and drugs

Test group

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients18 yo and older referred to out kidney stone clinic

You may qualify if:

  • yo and older
  • kidneys
  • Kidney or ureteric stone treated surgically or conservatively

You may not qualify if:

  • Single kidney
  • Aberrant kidney anatomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carmel Lady Davis Medical Center

Haifa, Israel

Location

MeSH Terms

Conditions

Kidney Calculi

Condition Hierarchy (Ancestors)

NephrolithiasisKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisUrinary CalculiMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

August 25, 2020

First Posted

September 11, 2020

Study Start

October 1, 2021

Primary Completion

September 1, 2022

Study Completion

December 1, 2022

Last Updated

October 14, 2022

Record last verified: 2022-10

Locations